Artwork

Content provided by Finimize. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Finimize or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ozempic Made Novo Nordisk a Giant. Here's Why It's Stock Might Be Undervalued

12:33
 
Share
 

Manage episode 489639953 series 3439723
Content provided by Finimize. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Finimize or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Ozempic’s still the hottest drug on the planet.

But Novo Nordisk’s stock? Not so much. It’s down nearly 50% from its peak, and investors aren’t sure whether to double down or walk away.

In today’s episode, Finimize Analyst Russell Burns, whose latest research unpack's what’s really going on with the stock, joins the pod.

Is this just a healthy correction? Or the kind of long-term opportunity you only get when everyone else is panicking?

Try Finimize Pro

  continue reading

132 episodes

Artwork
iconShare
 
Manage episode 489639953 series 3439723
Content provided by Finimize. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Finimize or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Ozempic’s still the hottest drug on the planet.

But Novo Nordisk’s stock? Not so much. It’s down nearly 50% from its peak, and investors aren’t sure whether to double down or walk away.

In today’s episode, Finimize Analyst Russell Burns, whose latest research unpack's what’s really going on with the stock, joins the pod.

Is this just a healthy correction? Or the kind of long-term opportunity you only get when everyone else is panicking?

Try Finimize Pro

  continue reading

132 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play